These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30004329)

  • 1. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa.
    Ebrahim I; Bryer A; Cohen K; Mouton JP; Msemburi W; Blockman M
    S Afr Med J; 2018 May; 108(6):490-494. PubMed ID: 30004329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
    PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International normalised ratio control in a non-metropolitan setting in Western Cape Province, South Africa.
    Prinsloo DN; Gould TJ; Viljoen CA; Basera W; Ntsekhe M
    S Afr Med J; 2021 Mar; 111(4):355-360. PubMed ID: 33944770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
    McAlister FA; Wiebe N; Hemmelgarn BR
    BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; OĊ‚tarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study.
    Jorgensen AL; Orrell C; Waitt C; Toh CH; Sekaggya-Wiltshire C; Hughes DA; Allen E; Okello E; Tatz G; Culeddu G; Asiimwe IG; Semakula JR; Mouton JP; Cohen K; Blockman M; Lamorde M; Pirmohamed M
    JMIR Res Protoc; 2023 Jul; 12():e46710. PubMed ID: 37467034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
    J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.
    Sonuga BO; Hellenberg DA; Cupido CS; Jaeger C
    Afr J Prim Health Care Fam Med; 2016 May; 8(1):e1-8. PubMed ID: 27247158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic.
    Lee SL; Ong TJ; Mazlan-Kepli W; Mageswaran A; Tan KH; Abd-Malek AM; Cronshaw R
    World J Cardiol; 2021 Sep; 13(9):483-492. PubMed ID: 34621493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
    Mwita JC; Francis JM; Pillay C; Ogah OS; Goshu DY; Agyekum F; Musonda JM; James MC; Tefera E; Kabo T; Ditlhabolo KI; Ndlovu K; Ayodele AY; Mikomangwa WP; Chillo P; Damasceno A; Folson AA; Oyekunle A; Tebuka E; Kalokola F; Forrest K; Dunn H; Karaye K; Jean-Pierre FL; Oljira CF; Assefa T; Taiwo TS; Nwafor CE; Omole O; Anakwue R; Cohen K
    J Thromb Thrombolysis; 2024 Apr; 57(4):613-621. PubMed ID: 38478250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.
    Jones M; McEwan P; Morgan CL; Peters JR; Goodfellow J; Currie CJ
    Heart; 2005 Apr; 91(4):472-7. PubMed ID: 15772203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of anticoagulation with warfarin in rural Chhattisgarh, India.
    Chebrolu P; Patil S; Laux TS; Al-Hammadi N; Jain Y; Gage B
    Indian J Med Res; 2020 Sep; 152(3):303-307. PubMed ID: 33107491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS).
    Harris DE; Thayer D; Wang T; Brooks C; Murley G; Gravenor M; Hill NR; Lister S; Halcox J
    Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):40-49. PubMed ID: 31774502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia.
    Liyew Z; Tadesse A; Bekele N; Tsegaye T
    Adv Hematol; 2021; 2021():7530997. PubMed ID: 34970315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.
    Bahbahani H; AlTurki A; Dawas A; Lipman ML
    BMC Nephrol; 2018 Jan; 19(1):4. PubMed ID: 29310600
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.